TrialPloS one2016

Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study.

Kwadwo A Koram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.